A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma

Clinical trial NCT02298153 · TERMINATED

Trial details

NCT number: NCT02298153
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Carcinoma)UC (Urothelial Cancer)

Start date: 2015-01-27
Primary completion: 2017-11-08
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.